News

Filter

Current filters:

Bexxar

1 to 9 of 56 results

Expanded indication for GSK's Bexxar

10-01-2005

GlaxoSmithKline says that the US Food and Drug Administration has approved a supplemental Biologics License…

BexxarBiogen IdecGlaxoSmithKlineGSKRituxanrituximabTositumomab and Iodine 1131 Tositumomab

GSK acquires full rights for Bexxar from Corixa

20-12-2004

UK drug major GlaxoSmithKline is to acquire the worldwide rights and responsibilities related to the…

BexxarBiogen IdecGlaxoSmithKlineGSKIbritumomab TiuxetanTositumomab and Iodine 1131 TositumomabZevalin

Corixa files sBLA in USA for Bexxar

12-07-2004

Corixa Corp, a developer of immunotherapeutics, says it has filed asupplemental Biologics License Application…

BexxarRituxanrituximabRocheTositumomab and Iodine 1131 Tositumomab

US court denies Biogen Idec's motion against Corixa's Bexxar patent

02-02-2004

Corixa has said that the US District Court, Southern District of California, has vacated its October…

BexxarBiogen IdecTositumomab and Iodine 1131 Tositumomab

Corixa/GSK's Bexxar launched in the USA

11-08-2003

Corixa and GlaxoSmithKline's Bexxar (tositumomab) is now available in the USA. This follows the recently-granted…

BexxarGenentechGlaxoSmithKlineGSKRituxanrituximabTositumomab and Iodine 1131 Tositumomab

1 to 9 of 56 results

COMPANY SPOTLIGHT

Menarini

Back to top